Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Patient-reported outcomes for keloids: a systematic review.

Tan A, Glass DA 2nd.

G Ital Dermatol Venereol. 2018 Oct 29. doi: 10.23736/S0392-0488.18.06089-3. [Epub ahead of print]

PMID:
30375208
2.

Novel therapeutic approaches to xeroderma pigmentosum.

Weon JL, Glass DA II.

Br J Dermatol. 2018 Sep 28. doi: 10.1111/bjd.17253. [Epub ahead of print] Review.

PMID:
30265743
3.

Multiple Tumors on the Extremities: Answer.

Ukoha UT, Vandergriff T, Cheng J, Glass DA 2nd.

Am J Dermatopathol. 2018 Aug;40(8):624-625. doi: 10.1097/DAD.0000000000000851. No abstract available.

PMID:
30028762
4.

Widespread Eruption of Comedones.

Kailas A, Vandergriff T, Glass DA 2nd.

Am J Dermatopathol. 2017 Dec 28. doi: 10.1097/DAD.0000000000001077. [Epub ahead of print] No abstract available.

PMID:
29293130
5.

Barber Knowledge and Recommendations Regarding Pseudofolliculitis Barbae and Acne Keloidalis Nuchae in an Urban Setting.

Adotama P, Tinker D, Mitchell K, Glass DA 2nd, Allen P.

JAMA Dermatol. 2017 Dec 1;153(12):1325-1326. doi: 10.1001/jamadermatol.2017.3668. No abstract available.

6.

Dermatology in Orbit: Anticipating Skincare Requirements in the Space Age.

Rutherford A, Glass DA 2nd, Savory S.

J Am Acad Dermatol. 2017 Sep 22. pii: S0190-9622(17)32451-9. doi: 10.1016/j.jaad.2017.09.046. [Epub ahead of print] No abstract available.

PMID:
28947284
7.

Current Understanding of the Genetic Causes of Keloid Formation.

Glass DA 2nd.

J Investig Dermatol Symp Proc. 2017 Oct;18(2):S50-S53. doi: 10.1016/j.jisp.2016.10.024. Review.

8.

Prescription-level factors associated with primary nonadherence to dermatologic medications.

Rutherford A, Glass DA, Suarez EA, Adamson AS.

J Dermatolog Treat. 2018 May;29(3):300-304. doi: 10.1080/09546634.2017.1365115. Epub 2017 Aug 18.

PMID:
28783420
9.

Osteoclast-Like Giant Cells in Malignant Melanoma: Unintentional Accident or Strategic Recruitment?

Li X, Savory S, Vandergriff T, Glass DA 2nd.

Am J Dermatopathol. 2018 Apr;40(4):303-304. doi: 10.1097/DAD.0000000000000860. No abstract available.

PMID:
28692466
10.

Patient-provider race and sex concordance and the risk for medication primary nonadherence.

Adamson AS, Glass DA 2nd, Suarez EA.

J Am Acad Dermatol. 2017 Jun;76(6):1193-1195. doi: 10.1016/j.jaad.2017.01.039. No abstract available.

PMID:
28522045
11.

A case-control study analyzing the association of keloids with hypertension and obesity.

Rutherford A, Glass DA 2nd.

Int J Dermatol. 2017 Sep;56(9):e187-e189. doi: 10.1111/ijd.13618. Epub 2017 May 11. No abstract available.

PMID:
28497468
Free PMC Article
12.

Multiple Tumors on the Extremities: Challenge.

Ukoha UT, Vandergriff T, Cheng J, Glass DA 2nd.

Am J Dermatopathol. 2018 Aug;40(8):e111. doi: 10.1097/DAD.0000000000000852. No abstract available.

PMID:
28410246
13.

A Novel Homozygous Missense Mutation in HOXC13 Leads to Autosomal Recessive Pure Hair and Nail Ectodermal Dysplasia.

Li X, Orseth ML, Smith JM, Brehm MA, Agim NG, Glass DA 2nd.

Pediatr Dermatol. 2017 Mar;34(2):172-175. doi: 10.1111/pde.13074.

PMID:
28297138
14.

Association of keloids with systemic medical conditions: a retrospective analysis.

Adotama P, Rutherford A, Glass DA 2nd.

Int J Dermatol. 2016 Jan;55(1):e38-40. doi: 10.1111/ijd.12969. Epub 2015 Oct 30. No abstract available.

PMID:
26517298
15.

Primary milia localized to the vulva.

Adotama P, Susa J, Glass DA 2nd.

Dermatol Online J. 2014 Apr 16;20(4):22339.

16.

Systemic lupus erythematosus in a patient with PTEN hamartoma tumour syndrome.

Lee T, Le EN, Glass DA 2nd, Bowen CD, Dominguez AR.

Br J Dermatol. 2014 Apr;170(4):990-2. doi: 10.1111/bjd.12767. No abstract available.

PMID:
24641667
17.

An unusual presentation of Gaucher disease in an infant with progressive dyspnea.

Levy JM, Glass DA, Rodriguez KH.

Ochsner J. 2013 Summer;13(2):270-2.

18.

JAAD Grand Rounds. Annular plaques and craniosynostosis.

Taylor A, Nguyen RH, Glass DA 2nd, Agim NG.

J Am Acad Dermatol. 2013 May;68(5):881-4. doi: 10.1016/j.jaad.2011.12.005. No abstract available.

PMID:
23602181
19.

Whole exome sequencing.

Glass DA 2nd, Nuara AA.

Dermatitis. 2013 Jan-Feb;24(1):33-4. doi: 10.1097/DER.0b013e3182759e43.

PMID:
23340397
20.

Painful toe ulcers.

Sanchez AT, Weaver SP, Glass DA 2nd.

J Fam Pract. 2013 Jan;62(1):37-8.

PMID:
23326821
21.

Two pediatric cases of Blau syndrome.

Glass DA 2nd, Maender J, Metry D.

Dermatol Online J. 2009 Dec 15;15(12):5. No abstract available.

22.

Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.

Sun G, Berthelot C, Li Y, Glass DA 2nd, George D, Pandya A, Kurzrock R, Duvic M.

J Am Acad Dermatol. 2009 Feb;60(2):231-5. doi: 10.1016/j.jaad.2008.09.063. Epub 2008 Nov 20.

PMID:
19026464
23.

In vivo analysis of Wnt signaling in bone.

Glass DA 2nd, Karsenty G.

Endocrinology. 2007 Jun;148(6):2630-4. Epub 2007 Mar 29. Review.

PMID:
17395705
24.

Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.

Glass DA 2nd, Karsenty G.

Ann N Y Acad Sci. 2006 Apr;1068:117-30.

PMID:
16831912
25.

Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.

Glass DA 2nd, Karsenty G.

Curr Top Dev Biol. 2006;73:43-84. Review.

PMID:
16782455
26.

WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature.

Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA.

Nature. 2005 Sep 15;437(7057):417-21.

27.

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G.

Dev Cell. 2005 May;8(5):751-64.

28.

A new insight into the formation of osteolytic lesions in multiple myeloma.

Glass DA 2nd, Patel MS, Karsenty G.

N Engl J Med. 2003 Dec 25;349(26):2479-80. No abstract available.

PMID:
14695406
29.

Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice.

Levasseur R, Barrios R, Elefteriou F, Glass DA 2nd, Lieberman MW, Karsenty G.

Endocrinology. 2003 Jul;144(7):2761-4.

PMID:
12810527
30.

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.

Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L.

J Cell Biol. 2002 Apr 15;157(2):303-14. Epub 2002 Apr 15.

31.

Supplemental Content

Loading ...
Support Center